Back to first-pass browser

First-pass extracted concept

nanoparticle-ultrasound theranostics

Candidate: concept label1 source documents4 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

nanoparticle-ultrasound synergy, NPs and US

Extracted Explainers

What the tool is doing

This concept combines ultrasound with nanoparticles so the particles can act as contrast agents, drug delivery vehicles, and energy mediators in cancer theranostics.

Source 1DOIPubMed

Resources required

It requires ultrasound-based therapeutic or imaging systems together with designed nanoplatforms.

Source 1DOIPubMed

What problem it solves

It addresses the need to couple diagnosis and treatment more effectively in breast and gynecologic cancers.

Source 1DOIPubMed

What it does not solve

The abstract does not show that it overcomes translational challenges, and those challenges are explicitly noted as ongoing.

Source 1DOIPubMed

Alternatives

The abstract contrasts this paradigm with conventional therapies, which have improved outcomes but still leave suboptimal survival and quality of life.

Source 1DOIPubMed

Evidence Snippets

The integration of US with nanotechnology has further expanded its potential, enabling nanoparticles (NPs) to function as contrast agents, drug delivery vehicles, and energy mediators in cancer theranostics.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1application scopesupports2025Source 1DOIPubMed

Nanoparticle-ultrasound synergy is applied in enhanced imaging, HIFU, sonodynamic therapy, and ultrasound-triggered drug delivery for breast and gynecologic cancers.

Quoted textsource-backed
We examine the biophysical mechanisms underlying US-based therapies, the design of multifunctional nanoplatforms, and their applications in enhanced imaging, high-intensity focused ultrasound (HIFU), sonodynamic therapy (SDT), and US-triggered drug delivery.
Claim 2capability statementsupports2025Source 1DOIPubMed

Ultrasound has emerged as a promising therapeutic tool because of its safety, deep tissue penetration, and real-time capabilities.

Quoted textsource-backed
In recent years, ultrasound (US) has emerged as a promising therapeutic tool, not only for its well-established role in diagnostic imaging but also for its safety, deep tissue penetration, and real-time capabilities.
Claim 3functional rolesupports2025Source 1DOIPubMed

Integrating ultrasound with nanotechnology enables nanoparticles to function as contrast agents, drug delivery vehicles, and energy mediators in cancer theranostics.

Quoted textsource-backed
The integration of US with nanotechnology has further expanded its potential, enabling nanoparticles (NPs) to function as contrast agents, drug delivery vehicles, and energy mediators in cancer theranostics.
Claim 4translational potentialsupports2025Source 1DOIPubMed

Nanoparticle-ultrasound technologies have the potential to transform the clinical management of breast, cervical, and ovarian cancers.

Quoted textsource-backed
Finally, we discuss the translational challenges and future prospects of these innovative technologies, emphasizing their potential to transform the clinical management of BC, CC, and OC.